Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study

Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...

More activity and Less Sitting may Reduce Risk of Hypertensive Disorders in Pregnancy

In a study including nearly 500 pregnant women in three U.S. cities from 2020-2025, sedentary behavior, sleep and physical ...